|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
13,870,000 |
Market
Cap: |
583.93(M) |
Last
Volume: |
2,897,500 |
Avg
Vol: |
64,821 |
52
Week Range: |
$17.67 - $38.49 |
|
Level
I Sector: |
Basic Materials |
Level
II Sector: |
Chemicals |
Level
III Sector: |
Specialty Chemicals |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NASDAQ COMPOSITE |
|
S&P SMALLCAP 600 |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Surmodics is a provider of surface modification technologies for intravascular medical devices and chemical components for in vitro diagnostic (IVD) immunoassay tests and microarrays. Co.'s segments are: Medical Device, which develops and manufactures vascular intervention medical device products and is engaged in Co.'s proprietary surface modification coating technologies that impart lubricity, pro-healing, biocompatibility characteristics, or drug-delivery capabilities to medical devices and delivery systems; and IVD, which manufactures and sells components for IVD immunoassay and molecular tests within the diagnostic, biomedical research, and life science markets.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
9,872 |
Total Sell Value |
$0 |
$0 |
$0 |
$335,339 |
Total People Sold |
0 |
0 |
0 |
3 |
Total Sell Transactions |
0 |
0 |
0 |
3 |
End Date |
2024-02-29 |
2023-11-28 |
2023-05-30 |
2022-05-30 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Duran Lise W |
VP & Gen Mgr, Regen Tech |
|
2008-03-21 |
4 |
D |
$40.07 |
$25,965 |
D/D |
(648) |
61,332 |
|
- |
|
Keough Steven J |
Sr VP/Gen Mgr Orth/Chf IP Cnsl |
|
2008-03-21 |
4 |
D |
$40.07 |
$25,925 |
D/D |
(647) |
19,943 |
|
- |
|
Astry Douglas P |
Gen Mgr, In Vitro Technologies |
|
2008-03-21 |
4 |
D |
$40.07 |
$12,983 |
D/D |
(324) |
6,377 |
|
- |
|
Anderson Aron B |
VP & Chief Scientific Officer |
|
2008-03-21 |
4 |
D |
$40.07 |
$25,965 |
D/D |
(648) |
35,985 |
|
- |
|
Lopez Paul A |
Vice President |
|
2008-01-28 |
4 |
D |
$46.82 |
$113,819 |
D/D |
(2,431) |
39,863 |
|
- |
|
Lopez Paul A |
Vice President |
|
2008-01-28 |
4 |
A |
$0.00 |
$0 |
D/D |
6,500 |
42,294 |
|
- |
|
Melrose Kendrick B |
Director |
|
2007-12-14 |
5 |
GD |
$0.00 |
$0 |
D/D |
10 |
263,930 |
|
- |
|
Keller Kenneth H |
Director |
|
2007-12-07 |
4 |
GD |
$0.00 |
$0 |
D/D |
100 |
18,700 |
|
- |
|
Ginsberg Peter L |
VPof Bus Devlpmt & Strat Plan |
|
2007-11-12 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
4,000 |
|
- |
|
Webster Jan M |
VP of HR |
|
2007-11-12 |
4 |
D |
$49.30 |
$64,484 |
D/D |
(1,308) |
5,647 |
|
- |
|
Webster Jan M |
VP of HR |
|
2007-11-12 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
6,955 |
|
- |
|
Robey Brian L |
VP & Gen Mgr Drug Delivery |
|
2007-11-12 |
4 |
D |
$49.30 |
$64,484 |
D/D |
(1,308) |
8,025 |
|
- |
|
Robey Brian L |
VP & Gen Mgr Drug Delivery |
|
2007-11-12 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
9,333 |
|
- |
|
Shoup Michael J |
VP of Qual, Reg & Clinical |
|
2007-11-12 |
4 |
D |
$49.30 |
$64,484 |
D/D |
(1,308) |
4,192 |
|
- |
|
Shoup Michael J |
VP of Qual, Reg & Clinical |
|
2007-11-12 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
5,500 |
|
- |
|
Olson Charles W |
VP & Gen Mgr, Hydroph Tech |
|
2007-11-12 |
4 |
D |
$49.30 |
$177,332 |
D/D |
(3,597) |
28,399 |
|
- |
|
Olson Charles W |
VP & Gen Mgr, Hydroph Tech |
|
2007-11-12 |
4 |
A |
$0.00 |
$0 |
D/D |
11,000 |
31,996 |
|
- |
|
Lopez Paul A |
Vice President |
|
2007-11-12 |
4 |
D |
$49.30 |
$229,097 |
D/D |
(4,647) |
35,794 |
|
- |
|
Lopez Paul A |
Vice President |
|
2007-11-12 |
4 |
A |
$0.00 |
$0 |
D/D |
13,000 |
40,441 |
|
- |
|
Keough Steven J |
Sr VP/Gen Mgr Orth/Chf IP Cnsl |
|
2007-11-12 |
4 |
D |
$49.30 |
$128,969 |
D/D |
(2,616) |
20,252 |
|
- |
|
Keough Steven J |
Sr VP/Gen Mgr Orth/Chf IP Cnsl |
|
2007-11-12 |
4 |
A |
$0.00 |
$0 |
D/D |
8,000 |
22,868 |
|
- |
|
Duran Lise W |
VP & Gen Mgr, Regen Tech |
|
2007-11-12 |
4 |
D |
$49.30 |
$128,969 |
D/D |
(2,616) |
61,463 |
|
- |
|
Duran Lise W |
VP & Gen Mgr, Regen Tech |
|
2007-11-12 |
4 |
A |
$0.00 |
$0 |
D/D |
8,000 |
64,079 |
|
- |
|
Barclay Bruce |
President & CEO |
|
2007-11-12 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
87,585 |
|
- |
|
Astry Douglas P |
Gen Mgr, In Vitro Technologies |
|
2007-11-12 |
4 |
D |
$49.30 |
$64,484 |
D/D |
(1,308) |
6,375 |
|
- |
|
888 Records found
|
|
Page 30 of 36 |
|
|